Deerfield, IL, United States of America

Charles S Markos


Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 37(Granted Patents)


Location History:

  • Skokie, IL (US) (1976)
  • Deerfield, IL (US) (1977)

Company Filing History:


Years Active: 1976-1977

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Charles S. Markos

Introduction

Charles S. Markos is a notable inventor based in Deerfield, IL (US). He has made significant contributions to the field of chemistry, particularly in the development of novel compounds and processes. With a total of 3 patents to his name, Markos has demonstrated a commitment to innovation and scientific advancement.

Latest Patents

Markos's latest patents include a process for the preparation of a new compound, specifically 17.beta.-hydroxy-3-oxo-17.alpha.-pregn-4-ene-21-carboxylic acid .gamma.-lactone. This innovative procedure utilizes readily available and inexpensive sarsasaponin as a starting material. Another significant invention encompasses novel 2-[5-(cyclic amino)ethyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl]-5-alkyl-1,3,4-oxadiazoles and congeners, which are useful as anti-diarrheal agents.

Career Highlights

Markos has had a distinguished career at G.D. Searle & Company, where he has been able to apply his expertise in chemistry to develop groundbreaking solutions. His work has not only contributed to the company’s portfolio but has also advanced the field of medicinal chemistry.

Collaborations

Throughout his career, Markos has collaborated with esteemed colleagues such as Chung H. Yen and Hugh L. Dryden, Jr. These partnerships have fostered an environment of innovation and have led to the successful development of various patented technologies.

Conclusion

Charles S. Markos is a prominent figure in the field of chemistry, with a focus on innovative processes and compounds. His contributions through patents and collaborations highlight his dedication to advancing scientific knowledge and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…